Finance

Lists
4582:TYO
Symbio Pharmaceuticals Ltd
56,00 JP¥
+1,82%
(+1,00) 1D
6-окт., 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4582...
Open
57 JP¥
High
57 JP¥
Low
56 JP¥
Mkt. cap
4,73 млд
Avg. vol.
730,92 миң
Volume
430,50 миң
52-wk high
229 JP¥
52-wk low
53 JP¥
EPS
-98 JP¥
Shares outstanding
82,40 млн
No. of employees
91
Open
57 JP¥
High
57 JP¥
Low
56 JP¥
Mkt. cap
4,73 млд
Avg. vol.
730,92 миң
Volume
430,50 миң
52-wk high
229 JP¥
52-wk low
53 JP¥
EPS
-98 JP¥
Shares outstanding
82,40 млн
No. of employees
91
News stories
From web sources and news partners
About Symbio Pharmaceuticals Ltd
CEO-
Employees91
Founded2005-ж., 25-мар.
HeadquartersMinato City, Tokyo, Япония
SectorPharmaceutical industry
Websitesymbiopharma.com
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
324,17 млн
336,19 млн
233,46 млн
235,54 млн
Cost of goods sold
122,29 млн
84,64 млн
60,63 млн
71,37 млн
Cost of revenue
122,29 млн
84,64 млн
60,63 млн
71,37 млн
Research and development expenses
868,70 млн
846,40 млн
1,99 млд
-1,99 млд
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
518,54 млн
506,73 млн
522,11 млн
3,45 млд
Operating expense
1,39 млд
1,35 млд
2,51 млд
1,46 млд
Total operating expenses
1,51 млд
1,44 млд
2,57 млд
1,53 млд
Operating income
-1,19 млд
-1,10 млд
-2,34 млд
-1,29 млд
Other non operating income
-1,57 млн
14,49 млн
-6,26 млн
85,26 млн
EBT including unusual items
-1,20 млд
-1,19 млд
-2,39 млд
-1,21 млд
EBT excluding unusual items
-1,20 млд
-1,09 млд
-2,39 млд
-1,22 млд
Income tax expense
-3,66 млн
18,88 млн
13,97 млн
4,03 млн
Effective tax rate
0,30%
-1,58%
-0,58%
-0,33%
Other operating expenses
-
-
-
-
Net income
-1,20 млд
-1,21 млд
-2,40 млд
-1,22 млд
Net profit margin
-369,09%
-360,02%
-1 028,60%
-516,94%
Earnings per share
-
-
-
-
Interest and investment income
1,73 млн
653,00 миң
2,25 млн
-
Interest expense
-29,04 млн
-11,12 млн
-16,63 млн
-16,62 млн
Net interest expenses
-27,31 млн
-10,47 млн
-14,38 млн
-16,62 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору